Bill of Health

SEPTEMBER 20, 2022

By December 2020, the world had astonishingly powerful tools against COVID-19. New mRNA vaccines, underpinned by decades of public investment , had been authorized by global regulators. The answer to one of the most important public health questions of our time — who gets access to vaccines? — By Zain Rizvi.

Public Health 246

Public Health COVID-19 World Health Governance 246

Bill of Health

AUGUST 29, 2022

On October 8, 2020, Moderna, the maker of one of the first mRNA-based vaccines for COVID-19 and the recipient of billions of dollars of U.S. In short, these public statements, if made in a manner that is intended to be taken seriously (e.g., On October 8, 2020, amid press coverage of an emerging inventorship dispute with the U.S.

COVID-19 Vaccine 362

COVID-19 Vaccine COVID-19 Licensing Governance 362

HIT Consultant

AUGUST 22, 2023

The World Health Organization declared 2020 the International Year of the Nurse and Midwife to spotlight nurses’ impact on healthcare and recognize the 200 th anniversary of Florence Nightingale’s birthday. Enabling nurses to practice at the top of their licenses. But it also shined a light on nurses’ courage and heroism.

Nurses 98

Nurses COVID-19 Licensing World Health 98

SQA

DECEMBER 16, 2022

This guidance will help applicants interpret how to implement Essential Principles of Medical Device Safety and Performance using information that was issued in March 2020. The EC presented a first draft for public comment to the revision of Annex 1 in 2017. CMDE Announcement No.

FDA 40

FDA Compliance COVID-19 Licensing 40

SQA

OCTOBER 18, 2022

Health Canada is warning consumers about counterfeit BTNX Rapid Response COVID-19 antigen rapid test kits (25-pack boxes) found in Ontario. The counterfeit devices were sold online by a distributor named Healthful Plus without the required license to import, distribute, or sell medical devices in Canada.

US Department of Health and Human Services 40

US Department of Health and Human Services FDA COVID-19 Compliance 40

SQA

FEBRUARY 26, 2024

This guidance does not intend to elaborate on aspects related to the clinical evaluation or cybersecurity for these products, as those are described in other guidelines ( MDCG 2020-1 on Clinical Evaluation (MDR) / Performance Evaluation (IVDR) of Medical Device Software; MDCG 2019-16 on Cybersecurity for medical devices).

FDA 52

FDA Compliance COVID-19 Public Health 52